Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.57 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.37 |
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.37 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.37 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.37 |
| ▸ | PSMA1 | P25786 | 1/20 | 0.37 |
| ▸ | PSMA2 | P25787 | 1/20 | 0.37 |
| ▸ | PSMA3 | P25788 | 1/20 | 0.37 |
| ▸ | PSMA4 | P25789 | 1/20 | 0.37 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.37 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.37 |
| ▸ | PSMA5 | P28066 | 1/20 | 0.37 |
| ▸ | PSMB4 | P28070 | 1/20 | 0.37 |
| ▸ | PSMB6 | P28072 | 1/20 | 0.37 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.37 |
| ▸ | PSMB10 | P40306 | 1/20 | 0.37 |
| ▸ | PSMB3 | P49720 | 1/20 | 0.37 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5409553 | 1.00 | TAS1R3 (0.57) | TAS1R3TAS1R1PTPN1HCAR2PSMB11 | |
| SCHEMBL28206614 | 0.81 | — | — | |
| SCHEMBL8089117 | 0.81 | — | — | |
| SCHEMBL22294215 | 0.81 | — | — | |
| SCHEMBL5411837 | 0.80 | ALDH1A1 (0.37) | TAS1R3TAS1R1HCAR2PPARGPPARA | |
| SCHEMBL5411842 | 0.80 | ALDH1A1 (0.37) | TAS1R3TAS1R1HCAR2PPARGPPARA | |
| (2E)-Hexenoic Acid SCHEMBL27373174 | 0.79 | TSHR (0.50) | TAS1R3TAS1R1PTPN1HCAR2PPARG | |
| (2E)-Hexenoic Acid SCHEMBL23615 | 0.79 | — | — | |
| (2E)-Hexenoic Acid SCHEMBL23614 | 0.79 | — | — | |
| (2E)-Hexenoic Acid SCHEMBL3048610 | 0.79 | TSHR (0.50) | TAS1R3TAS1R1PTPN1HCAR2PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7232923-B2 | Method of hydroaminating N-alkenoylcarbamates with primary aromatic amines | IMPERIAL INNOVATIONS LIMITED (GB) | 2007-06-19 | — | — | US | disclosed |
| US-20060183933-A1 | Method of hydroaminating N-alkenoylcarbamates with primary aromatic amines | IMPERIAL COLLEGE INNOVATION LIMITED (GB) | 2006-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183933-A1 | Method of hydroaminating N-alkenoylcarbamates with primary aromatic amines | ALKBH3, HNMT, ALKBH1 | TAS1R3 1087/4885TAS1R1 2143/4885PTPN1 4634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.